IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 8.00
+0.50 (6.67%)
Sep 25, 2026, 8:41 AM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 16.42 million as of September 24, 2026. Its market cap has increased by 54.11% in one year.
Market Cap
16.42M
Enterprise Value
15.31M
Revenue
7.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.00
ChartMarket Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 16.42M, an increase of 86.16%. That is a compound annual growth rate of 4.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 16.42M | 50.83% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 33.41M |
| Hemogenyx Pharmaceuticals | 30.94M |
| ImmuPharma | 24.89M |
| Oxford BioDynamics | 15.46M |
| SkinBioTherapeutics | 14.90M |
| Fusion Antibodies | 14.02M |
| Palatin Technologies | 12.90M |
| Aptamer Group | 11.23M |